BHVN SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0000919574-26-005259
BHVN filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 14, 2026. A Schedule 13G was filed regarding Biohaven Ltd. (BHVN), indicating a passive ownership position by an institutional or other holder. The stock moved -1.4% by the first close after the filing.
Summary of the filing
A Schedule 13G was filed regarding Biohaven Ltd. (BHVN), indicating a passive ownership position by an institutional or other holder. The filing does not disclose a change in control intent or activist plans.
Key details
How BHVN stock reacted
Close before
$14.85
Aug 13, 2026
First close after
-1.41%
$14.64
5 trading days
-9.09%
$13.50
Since filing
-2.49%
$14.48
✦ Ask GOAX AI about this filing — what it means for BHVN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BHVN?
Click hereFrequently asked questions
What did BHVN file with the SEC on Aug 14, 2026?
BHVN filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Biohaven Ltd. (BHVN), indicating a passive ownership position by an institutional or other holder. The filing does not disclose a change in control intent or activist plans.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did BHVN stock react to this filing?
BHVN closed at $14.85 before the filing and $14.64 on Aug 14, 2026 (-1.41%). Five trading days later: $13.50 (-9.09%).
Other BHVN SEC filings
- 10-Q · SEC filingOct 29, 2026
- 8-K · Guidance raiseOct 29, 2026
- 8-K · Fda approvalOct 22, 2026
- 8-K · Material agreementOct 15, 2026
- 8-K · Regulatory actionSep 10, 2026
- 8-K · Material agreementAug 26, 2026
- 8-K · Guidance raiseAug 10, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · Board changeAug 7, 2026
- 8-K · Executive departureJul 9, 2026
Get alerts when BHVN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days